Searchable abstracts of presentations at key conferences in endocrinology

ea0069p11 | Poster Presentations | SFENCC2020

Autoimmune hypophysitis induced by Anti-PD-1 Monoclonal Antibody, Nivolumab and anticytotoxic T-lymphocyte antigen-4 (CTLA-4) agent, Ipilimumab, presenting by compressive symptoms and treated with intravenous methyl-prednisolone

Ahmed Ahmed M Gharib , Lambert Paul

We are a presenting a 57 year old male victim of recurrent metastatic melanoma who was treated surgically in 2015 by wide local excision together with right axillary dissection for axillary nodal spread. He re-presented to dermatology clinic in December 2018 with skin lesion that was histologically proven to be a BRAF-mutant malignant melanoma. CT scans at that time showed spread to mediastinal and hilar nodes. Oncology team decided to commence Iplimumab/Nivolumab combination ...